1. Home
  2. AAME vs ATOS Comparison

AAME vs ATOS Comparison

Compare AAME & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

HOLD

Current Price

$1.75

Market Cap

41.4M

Sector

Finance

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$1.82

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAME
ATOS
Founded
1968
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.4M
36.2M
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
AAME
ATOS
Price
$1.75
$1.82
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$23.00
AVG Volume (30 Days)
14.8K
270.6K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$188,227,000.00
$1,758.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.64
N/A
Revenue Growth
0.77
N/A
52 Week Low
$1.59
$0.53
52 Week High
$3.71
$7.56

Technical Indicators

Market Signals
Indicator
AAME
ATOS
Relative Strength Index (RSI) 37.67 18.41
Support Level $1.59 $0.63
Resistance Level $3.16 $6.18
Average True Range (ATR) 0.10 0.20
MACD 0.01 -0.11
Stochastic Oscillator 43.33 4.67

Price Performance

Historical Comparison
AAME
ATOS

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: